T1	Participants 136 190	stroke prevention in patients with atrial fibrillation
T2	Participants 312 363	patients with non-valvular atrial fibrillation (AF)
T3	Participants 398 473	multicentre, multinational study, 1,146 patients with AF and risk of stroke
T4	Participants 835 894	Mean age was 65 +/- 8.7 years and 64.4% were warfarin-na√Øve
